Evidence map›Paper›PMID 41137518›Full record

ArticlePest management science2026

Acaricidal activity of small molecule antagonists of the tick kinin receptor against Rhipicephalus microplus acaricide-susceptible and resistant strains.

Waleed M Arafa, Kimberly H Lohmeyer, Patricia V Pietrantonio

Abstract read
In one paragraph

Article in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Waleed M ArafaDepartment of Entomology, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0002-9420-1764
Kimberly H LohmeyerKnipling-Bushland U.S. Livestock Insects Research Laboratory, USDA-ARS, Kerrville, Texas, USA.
Patricia V PietrantonioDepartment of Entomology, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0001-7870-7266

Funding

USDA NIFA
6 · The paper itself

Abstract

backgroundResistance to acaricides underscores the need for tick control alternatives. We previously identified in a high-throughput screen six small molecules SACC-0412060, SACC-0412062, SACC-0412066, SACC-0064443, SACC-0428788, and SACC-0039590 as antagonists of the kinin receptor from Rhipicephalus microplus. The acaricidal activity of these molecules was investigated.

resultsThe toxicities of adjuvant/solvent combinations of a rapeseed oil methyl ester or a propylene carbonate in 5% DMSO versus 5% DMSO alone were evaluated using a larval immersion test (LIT) with the R. microplus susceptible Deutch strain, and all were non-toxic. The rapeseed oil methyl ester (1%) in 5% DMSO was adopted as the adjuvant for all molecules in bioassays. Permethrin (3.19 mM) killed all larvae. The Deutch strain mortality with SACC-0039590 and SACC-0428788 (both at 1 mM) was 100% and 73.65%, respectively, while ranged from 2.7% to 3.8% with the other small molecules. In the LIT, the LC

conclusionThe small molecule SACC-0039590 killed susceptible and pyrethroid-resistant larvae of R. microplus and reduced the reproductive output of females. © 2025 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

Indexed as

AcaricidesArthropod ProteinsDrug ResistanceRhipicephalusAnimalsLarvaReceptors, Biogenic AmineAcaricidesArthropod Proteinsnorsynephrine receptorReceptors, Biogenic Aminecattle fever tickDMSOG protein‐coupled receptorkinin receptor antagonistslarval and adult immersion testmethylated rapeseed oilprobit analysis

Identifiers

PMID41137518
PMCPMC12790644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.